Tag | Content |
---|
EnhancerAtlas ID | HS187-16053 |
Organism | Homo sapiens |
Tissue/cell | Th1 |
Coordinate | chr22:20925250-20926180 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
CTCF | MA0139.1 | chr22:20925953-20925972 | CAGCGCCCCCTGCTGGGGG | - | 6.82 | EN2 | MA0642.1 | chr22:20925915-20925925 | GCTAATTGGG | - | 6.02 | ZEB1 | MA0103.3 | chr22:20925695-20925706 | CCCACCTGCCC | + | 6.14 |
|
| Number of super-enhancer constituents: 8 | ID | Coordinate | Tissue/cell |
SE_00966 | chr22:20925353-20925913 | Adrenal_Gland | SE_20611 | chr22:20925004-20927055 | CD56 | SE_22532 | chr22:20925066-20926762 | CD8_primiary | SE_36960 | chr22:20919783-20925974 | HSMMtube | SE_43192 | chr22:20925243-20926089 | Lung | SE_44170 | chr22:20925198-20926476 | NHDF-Ad | SE_45715 | chr22:20925070-20926695 | Osteoblasts | SE_53780 | chr22:20925060-20926211 | Spleen |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH22I020562 | chr22 | 20917106 | 20926342 |
|
Enhancer Sequence | GGGCCAGGCT GGTCTTAAGC TCCTGACTTC AAGTGATCCA CCTGCCTCAG CCTCCCTAAG 60 TGTTGGGATT ACAGGCGTGA GCCACTGTGC CCAGCCGAAC TTTCCTTTTC TTTCCATTTC 120 TTGGTATTTG GAAAGTGAAT AGCCATGGAG CAGCCAGTGT TTTCAGCTGG TGCAGGCCCA 180 GCTGGTATGT TCGTTAGGCT TCTAGCTCAA GGAAGTGTCC ACTCTGCAGT CTCACTGGCA 240 TCCCATCACC GTCCAGAAGC AGGATGCCAG CTGTGTGTGC TCATGGCCCA TGCTGAGCCT 300 GTCCTTGGGC CACTGGTCTT CCTGTCGGTT TCTCCACCCC TTGTTTCAGG TGGAGGTCCC 360 CGCCCGACTG GCACAGGAAG GAGGATGGAG AGTGGTTACC ACTGTGGTTC GTTGCTGAGT 420 GAGTTTGATG TTTTAAGGAT CATTGCCCAC CTGCCCTGTG GCACCATGTG CTGCCATGCA 480 GGGGATTCCC AAGTGCTAGT GGCAGAGGAG CCTTGTAGTT TCTCAAAGTC CAGCAGTGGG 540 TAGGGCGTAT CTATGAGGTG CTTCTCAGTC CAGATGTGGC ACCTTGAAAT TCTGTAACCC 600 GCATTCTGCT GGTTTTCTCT CAGAGCTTGG TCTTGCCTTG TTGCAAGCAG TGCAGTTTCT 660 TGGGGGCTAA TTGGGCACCC TCACTGCCTT GTTCCACCAA TAGCAGCGCC CCCTGCTGGG 720 GGATGGGGAG GGTTGGGCAC AGCAAGCCCT CTGAGGGGCC ATCTGGATTC ATGATCTTCT 780 TTTGAAACTT GAATTGGCAC AGTGACCAGC TGAGGCTACG GTACTCTGAT CTAAAAACTT 840 TAAAAGTATG TGTGGTAACT GTAGAACCCA GAAAGTGGAG AGGAACAGAA GTAAGAGAAC 900 CATTCCATGA GAGAGAAGGT CTGGTGTCCT 930
|